Category: Antibody Technologies
Antibody Technologies market research reports by Icon Group International, Inc.
-
The 2023-2028 World Outlook for Antibody Drug Conjugates
The 2023-2028 World Outlook for Antibody Drug Conjugates This study covers the world outlook for antibody drug conjugates across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2023-2028 World Outlook for Antibody Drugs
The 2023-2028 World Outlook for Antibody Drugs This study covers the world outlook for antibody drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), ... Read More
-
The 2023-2028 World Outlook for Antivenom Serum
The 2023-2028 World Outlook for Antivenom Serum This study covers the world outlook for antivenom serum across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More
-
The 2023-2028 World Outlook for Gastric Cancer Monoclonal Antibodies (mAb)
The 2023-2028 World Outlook for Gastric Cancer Monoclonal Antibodies (mAb) This study covers the world outlook for gastric cancer monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More
-
The 2023-2028 World Outlook for Monoclonal Antibodies (mAbs)
The 2023-2028 World Outlook for Monoclonal Antibodies (mAbs) This study covers the world outlook for monoclonal antibodies (mAbs) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2023-2028 World Outlook for Antinuclear Antibody Test Assay Kits and Reagents
The 2023-2028 World Outlook for Antinuclear Antibody Test Assay Kits and Reagents This study covers the world outlook for antinuclear antibody test assay kits and reagents across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earning ... Read More
-
The 2023-2028 World Outlook for Catalog Antibody Immunochemicals
The 2023-2028 World Outlook for Catalog Antibody Immunochemicals This study covers the world outlook for catalog antibody immunochemicals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in que ... Read More
-
The 2023-2028 World Outlook for Combination Antibody Therapies
The 2023-2028 World Outlook for Combination Antibody Therapies This study covers the world outlook for combination antibody therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2023-2028 World Outlook for Esophageal Cancer Monoclonal Antibodies (mAb)
The 2023-2028 World Outlook for Esophageal Cancer Monoclonal Antibodies (mAb) This study covers the world outlook for esophageal cancer monoclonal antibodies (mAb) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E ... Read More
-
The 2023-2028 World Outlook for HER2 Antibodies
The 2023-2028 World Outlook for HER2 Antibodies This study covers the world outlook for HER2 antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars ... Read More
-
The 2023-2028 World Outlook for Monoclonal Antibodies for Inflammatory Diseases
The 2023-2028 World Outlook for Monoclonal Antibodies for Inflammatory Diseases This study covers the world outlook for monoclonal antibodies for inflammatory diseases across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P ... Read More
-
The 2023-2028 World Outlook for Neuroscience Antibodies and Assays
The 2023-2028 World Outlook for Neuroscience Antibodies and Assays This study covers the world outlook for neuroscience antibodies and assays across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More
-
The 2023-2028 World Outlook for Neuroscience Antibodies and Assays Consumables
The 2023-2028 World Outlook for Neuroscience Antibodies and Assays Consumables This study covers the world outlook for neuroscience antibodies and assays consumables across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I ... Read More
-
The 2023-2028 World Outlook for Next-Generation Antibodies
The 2023-2028 World Outlook for Next-Generation Antibodies This study covers the world outlook for next-generation antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2023-2028 World Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products
The 2023-2028 World Outlook for Therapeutic Monoclonal Antibody (Mab)-Based Products This study covers the world outlook for therapeutic monoclonal antibody (mab)-based products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry e ... Read More
-
The 2023-2028 World Outlook for Subcutaneous Immunoglobulin for Primary Immunodeficiency Diseases
The 2023-2028 World Outlook for Subcutaneous Immunoglobulin for Primary Immunodeficiency Diseases This study covers the world outlook for subcutaneous immunoglobulin for primary immunodeficiency diseases across more than 190 countries. For each year reported, estimates are given for the latent deman ... Read More
-
The 2023-2028 World Outlook for Bioengineered Monoclonal Antibodies Protein Drugs
The 2023-2028 World Outlook for Bioengineered Monoclonal Antibodies Protein Drugs This study covers the world outlook for bioengineered monoclonal antibodies protein drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earning ... Read More
-
The 2023-2028 World Outlook for Radioimmunoassays
The 2023-2028 World Outlook for Radioimmunoassays This study covers the world outlook for radioimmunoassays across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dol ... Read More
-
The 2023-2028 World Outlook for Therapeutic Monoclonal Antibodies
The 2023-2028 World Outlook for Therapeutic Monoclonal Antibodies This study covers the world outlook for therapeutic monoclonal antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2023-2028 World Outlook for Monoclonal Antibodies Protein Therapeutics
The 2023-2028 World Outlook for Monoclonal Antibodies Protein Therapeutics This study covers the world outlook for monoclonal antibodies protein therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More
-
The 2023-2028 World Outlook for Anti-HA Antibodies
The 2023-2028 World Outlook for Anti-HA Antibodies This study covers the world outlook for anti-HA antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. d ... Read More
-
The 2023-2028 World Outlook for Antibodies
The 2023-2028 World Outlook for Antibodies This study covers the world outlook for antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the per ... Read More
-
The 2023-2028 World Outlook for Antibody Production
The 2023-2028 World Outlook for Antibody Production This study covers the world outlook for antibody production across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. ... Read More
-
The 2023-2028 World Outlook for Antinuclear Antibody Testing
The 2023-2028 World Outlook for Antinuclear Antibody Testing This study covers the world outlook for antinuclear antibody testing across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2023-2028 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies
The 2023-2028 World Outlook for Chemotherapy and Antibody Combination Antibody Therapies This study covers the world outlook for chemotherapy and antibody combination antibody therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential in ... Read More
Research Assistance
